Cargando…

Riluzole: real-world evidence supports significant extension of median survival times in patients with amyotrophic lateral sclerosis

Amyotrophic lateral sclerosis (ALS) is the commonest form of motor neuron disease and is a fatal, degenerative, multisystem disorder affecting upper and/or lower motor neurons in the motor cortex, brain stem, and spinal cord. ALS is characterized by progressive atrophy of associated bulbar, limb, th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hinchcliffe, Michael, Smith, Alan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2017
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6053101/ https://www.ncbi.nlm.nih.gov/pubmed/30050378 http://dx.doi.org/10.2147/DNND.S135748

Ejemplares similares

Riluzole and Edavarone: The Hope Against Amyotrophic Lateral Sclerosis
por: Rokade, Aditi V, et al.
Publicado: (2022)

Early initiation of riluzole may improve absolute survival in amyotrophic lateral sclerosis
por: Thakore, Nimish J., et al.
Publicado: (2022)

Adherence to riluzole in patients with amyotrophic lateral sclerosis: an observational study
por: Introna, Alessandro, et al.
Publicado: (2018)

Riluzole is associated with decreasing neuritic plaque severity in amyotrophic lateral sclerosis
por: Mazumder, Srestha, et al.
Publicado: (2022)

Riluzole prescribing, uptake and treatment discontinuation in people with amyotrophic lateral sclerosis in Scotland
por: Jayaprakash, Kiran, et al.
Publicado: (2020)

Administration of Riluzole Oral Suspension During the Different Stages of Amyotrophic Lateral Sclerosis
por: Povedano Panades, Mónica, et al.
Publicado: (2021)

Riluzole 5 mg/mL oral suspension: for optimized drug delivery in amyotrophic lateral sclerosis
por: Dyer, Ann Margaret, et al.
Publicado: (2016)

Riluzole Selective Antioxidant Effects in Cell Models Expressing Amyotrophic Lateral Sclerosis Endophenotypes
por: Sala, Gessica, et al.
Publicado: (2019)

Dysphagia in Amyotrophic Lateral Sclerosis: Impact on Patient Behavior, Diet Adaptation, and Riluzole Management
por: Onesti, Emanuela, et al.
Publicado: (2017)

Assessment of Therapeutic Response of Edaravone and Riluzole Combination Therapy in Amyotrophic Lateral Sclerosis Patients
por: Samadhiya, Swapnil, et al.
Publicado: (2022)

Long-Term Use of Riluzole Could Improve the Prognosis of Sporadic Amyotrophic Lateral Sclerosis Patients: A Real-World Cohort Study in China
por: Chen, Lu, et al.
Publicado: (2016)

Median Nerve-Neurophysiological Index Correlates With the Survival of Patients With Amyotrophic Lateral Sclerosis
por: Xu, Liu-Qing, et al.
Publicado: (2020)

Partial Block by Riluzole of Muscle Sodium Channels in Myotubes from Amyotrophic Lateral Sclerosis Patients
por: Deflorio, Cristina, et al.
Publicado: (2014)

Riluzole–Rasagiline Hybrids: Toward the Development of Multi-Target-Directed Ligands for Amyotrophic Lateral Sclerosis
por: Albertini, Claudia, et al.
Publicado: (2022)

A Randomized, Double Blind, Placebo-Controlled Trial of Pioglitazone in Combination with Riluzole in Amyotrophic Lateral Sclerosis
por: Dupuis, Luc, et al.
Publicado: (2012)

From Riluzole to Dexpramipexole via Substituted-Benzothiazole Derivatives for Amyotrophic Lateral Sclerosis Disease Treatment: Case Studies
por: Mignani, Serge, et al.
Publicado: (2020)

In silico studies reveal structural deviations of mutant profilin-1 and interaction with riluzole and edaravone in amyotrophic lateral sclerosis
por: Sadr, Ahmad Shahir, et al.
Publicado: (2021)

Functional connectivity–based prediction of global cognition and motor function in riluzole-naive amyotrophic lateral sclerosis patients
por: Wei, Luqing, et al.
Publicado: (2022)

Repeated neurofilament light chain measurements did not capture Riluzole therapeutic effect in amyotrophic lateral sclerosis patients
por: Esselin, Florence, et al.
Publicado: (2022)

Riluzole and Prognostic Factors in Amyotrophic Lateral Sclerosis Long-term and Short-term Survival: A Population-Based Study of 1149 Cases in Taiwan
por: Lee, Charles Tzu-Chi, et al.
Publicado: (2013)

Interstitial pneumonia and other adverse events in riluzole-administered amyotrophic lateral sclerosis patients: a retrospective observational study
por: Inoue-Shibui, Aya, et al.
Publicado: (2019)

Stage at which riluzole treatment prolongs survival in patients with amyotrophic lateral sclerosis: a retrospective analysis of data from a dose-ranging study
por: Fang, Ton, et al.
Publicado: (2018)

Spinal cord and brain concentrations of riluzole after oral and intrathecal administration: A potential new treatment route for amyotrophic lateral sclerosis
por: Keifer, Orion P., et al.
Publicado: (2023)

“Huoling Shengji granule” for amyotrophic lateral sclerosis: protocol for a multicenter, randomized, double-blind, riluzole parallel controlled clinical trial
por: Liu, Xiaolu, et al.
Publicado: (2023)

Pilot Study of Real-World Monitoring of the Heart Rate Variability in Amyotrophic Lateral Sclerosis
por: Brown, Alexander A., et al.
Publicado: (2022)

Association of Lead Exposure with Survival in Amyotrophic Lateral Sclerosis
por: Kamel, Freya, et al.
Publicado: (2008)

Unraveling the Complexity of Amyotrophic Lateral Sclerosis Survival Prediction
por: Pfohl, Stephen R., et al.
Publicado: (2018)

Evaluating the cerebral correlates of survival in amyotrophic lateral sclerosis
por: Ishaque, Abdullah, et al.
Publicado: (2018)

Predicting functional decline and survival in amyotrophic lateral sclerosis
por: Ong, Mei-Lyn, et al.
Publicado: (2017)

Repetitive nerve stimulation on survival in amyotrophic lateral sclerosis
por: Zhu, Yahui, et al.
Publicado: (2023)

Amyotrophic lateral sclerosis
por: Wijesekera, Lokesh C, et al.
Publicado: (2009)

Clinical Significance of TDP-43 Neuropathology in Amyotrophic Lateral Sclerosis
por: Cykowski, Matthew D., et al.
Publicado: (2017)

Rethinking to riluzole mechanism of action: the molecular link among protein kinase CK1δ activity, TDP-43 phosphorylation, and amyotrophic lateral sclerosis pharmacological treatment
por: Bissaro, Maicol, et al.
Publicado: (2019)

Free fatty acids support oligodendrocyte survival in a mouse model of amyotrophic lateral sclerosis
por: Maruyama, Takashi, et al.
Publicado: (2023)

Platelet Serotonin Level Predicts Survival in Amyotrophic Lateral Sclerosis
por: Dupuis, Luc, et al.
Publicado: (2010)

Regulatory T-lymphocytes mediate amyotrophic lateral sclerosis progression and survival
por: Henkel, Jenny S, et al.
Publicado: (2013)

Regulatory T-lymphocytes mediate amyotrophic lateral sclerosis progression and survival
por: Henkel, Jenny S, et al.
Publicado: (2013)

Adipose Tissue Distribution Predicts Survival in Amyotrophic Lateral Sclerosis
por: Lindauer, Eva, et al.
Publicado: (2013)

Behavior Matters—Cognitive Predictors of Survival in Amyotrophic Lateral Sclerosis
por: Hu, William T., et al.
Publicado: (2013)

Maximizing the Survival of Amyotrophic Lateral Sclerosis Patients: Current Perspectives
por: Khairoalsindi, Osama A., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_10e0sov38kcddljmc7bailcn4q